
China-focused private equity manager investing in late-stage and buyout deals in consumer, healthcare and technology

Investment adviser managing public and private healthcare equity strategies for investors worldwide

Healthcare equities are the only market that Sectoral Asset Management works in. The firm is an investment adviser working only in global healthcare, running both listed and privately held equity portfolios for clients worldwide. It was founded in October 2000, is registered with the US Securities and Exchange Commission, and is owned entirely by its employees.
The firm currently offers four healthcare strategies. The Global Healthcare strategy covers the worldwide healthcare sector. The Emerging Markets Healthcare strategy targets healthcare businesses in developing economies, while the Small and Mid Cap Healthcare and Biotech strategy concentrates on smaller listed companies. Sectoral says it has managed biotech equities for one of the longest track records in the industry, and it uses that experience across each of its strategies.
The New Emerging Medical Opportunities strategy, known as NEMO, was launched at the end of 2007. It focuses on companies that develop new pharmaceuticals, medical technology devices and related products for the global healthcare market. The firm says that investing in late-stage companies allows NEMO to capture value that might otherwise be missed, because these businesses have moved past the riskiest development stages while still offering room to grow.
Sectoral's employee ownership is part of its identity as a firm. Its registration with the SEC as an investment adviser means it works under US regulatory oversight, and its offices in Montreal, Geneva and Hong Kong give it a presence in three financial centres. The firm describes its work as a combination of long experience, a single focus on healthcare and a team that shares in the results of its investment decisions.
The firm's clients are investors around the world who want exposure to healthcare equities. Its sector focus means its research and portfolio decisions are shaped by the growth of drug development, medical devices and biotech. Sectoral also keeps a venture capital and industry partner network, and its published material highlights recent financing rounds among the companies it follows, which it presents as a sign of how the sector is developing.
Sectoral Asset Management is an investment adviser that works only in the global healthcare sector. It manages public and private equity strategies for investors around the world and is registered as an investment adviser with the SEC.
The firm was founded in October 2000 and is fully owned by its employees. It reports having one of the longer track records in managing biotech equities.
Investors around the world seeking exposure to healthcare equities.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Sectoral Asset Management is ranked on 2 TrustList rankings: #2 on 1 and #7 on 1.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Sectoral Asset Management has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is the only one of the 9 here listing asset management and medical.
Its profile: “Its registration with the SEC as an investment adviser means it works under US regulatory oversight, and its offices in Montreal, Geneva and Hong Kong give it a presence in three financial centres.”
Of the 9 here, 2 also cover series a and 2 also cover biotech; 6 also work in Toronto and 4 also work in New York City.
Behind Sanderling Ventures, ahead of Kreos Capital.
It is one of 3 here listing asset management and one of 6 here listing medical.
Its profile: “Its registration with the SEC as an investment adviser means it works under US regulatory oversight, and its offices in Montreal, Geneva and Hong Kong give it a presence in three financial centres.”
Of the 48 here, 8 also cover series and 6 also cover early stage; 19 also work in London and 16 also work in Shanghai.
Behind Winton Capital Management, ahead of ADM Capital.
As of 2026-11-16. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Sectoral Asset Management.
Similar listings buyers compare against this one.

China-focused private equity manager investing in late-stage and buyout deals in consumer, healthcare and technology

Midwest venture capital firm investing in early-stage healthcare companies, from diagnostics to life science tools

Founder-first venture capital firm investing across sectors in startups worldwide, with a global founder community

European venture capital firm investing in early- and growth-stage life science companies

Growth-capital manager offering tax-advantaged investment portfolios in technology, life sciences and renewable energy

Cairo-focused venture capital firm backing technology founders in Egypt and the wider Middle East and Africa

Venture firm building companies that apply life science technology to problems in healthcare and beyond

Spanish venture capital manager investing in biotechnology and healthcare through life sciences funds
Everything here links back to the same verified catalogue. Pick your next stop.